Abstract
The practice of injecting phosphatidylcholine/sodium deoxycholate compounds into subcutaneous fat is growing rapidly. As with any new procedure, a standard of practice should be developed so that practitioners maintain patient safety as the primary goal. Efficacy and predictability of outcome are another priority. As injection lipolysis, also known as “lipodissolve,” becomes more accepted, many standards are being set, such as indications, contraindications, acceptable postinjection sequelae, best regions to treat, regions to avoid, and expected outcomes. This article establishes a basis of practice for the practitioner interested in adding this procedure to his or her repertoire.
Similar content being viewed by others
References
Duncan DI, Chubaty R (2006) Clinical safety data and standards of practice for injection lipolysis: A retrospective study. Aesth Surg J 26:575–585
Palmer M, Curran J, Bowler P (2006) Clinical experience and safety using phosphatidylcholine injections for the localized reduction of subcutaneous fat: A multicentre, retrospective UK study. J Cosmetic Derm 5:218–226
Rotunda A (2006) Overview of Mesotherapy and Injection Lipolysis. International Mesolipotherapy instructional course. Las Vegas
LeCoz J (2004) Traite de Mesoterapie. Masson, Paris, pp 7–9
Duncan DI, Hasengschwandtner F (2005) Lipodissolve for subcutaneous fat reduction and skin retraction. Aesth Surg J 25:530–543
Rohrich RJ (2005) Mesotherapy: What is it? Does it work? Plast Reconstr Surg 115:1425
The American Society of Aesthetic Plastic Surgery (2004) Fat-Melting Fad: Too Good to Be True? (Internet) American Society for Aesthetic Plastic Surgery: New York. Available at http://www.surgery.org./press/news-release
The American Society of Aesthetic Plastic Surgery (2007) Position Statement on Injection Lipolysis, New York, NY
Bryant R (2004) Controversial mesotherapy: Could it be the next Botox? Dermatology Times, pp 1–2
Rittes PG (2001) The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg 27:391–392
Rittes PG (2003) The use of phosphatidylcholine for correction of localized fat deposits. Aesth Surg J 27:315–318
Hexsel D, Serra M, Mazzuco R et al (2003) Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2:511–518
Hasengschwandtner F. Lipodissolve Injections for Effective Reduction of Localized Fat as a Nonsurgical Option to Minor Lipoplasty. 2003–2004 Clinical Study. Network Lipodissolve members report, Bad Leonfelden
Duncan DI (2006) The Evolution of Mesotherapy. ASPS Breast and Body Contouring Symposium, Santa Fe
Hasengschwandtner F (2006) Injection lipolysis for effective reduction of localized fat in the place of minor lipoplasty. Aesth Surg J 26:125–130
Popp G, Hernuss P et al Lipodissolve Injections in Follow-up for Correctional Treatment After Lipoplasty. World Congress on Liposuction Surgery, 1–3 October, St. Louis, MO
Ablon G, Rotunda AM (2004) Treatment of lower eyelid fat pads using phosphatidylcholine: Clinical trial and review. Dermatol Surg 30:422–427
Rullan P, Hexsel D (2005) Phosphatidylcholine Injections for Lipolysis of Neck and Jowls: 50-Case Presentation. American Society for Dermatologic Surgery–American College of Mohs Micrographic Surgery and Cutaneous Oncology combined annual meeting
Rose PT, Morgan M (2005) Histological changes associated with mesotherapy for fat dissolution. J Cosmet Laser Ther 7:17–19
Duncan DI (2005) Precision and Finesse in Injection Lipolysis. Congress of Network Lipodissolve, Paris
Rittes PG (2007) Injection Lipolysis: Technique and Results. International Mesolipotherapy Society instructional course, Nashville
Salas P (2006) Injection Lipolysis With Phosphatidylcholine. ASAPS annual meeting, Orlando, FL
Walsh N (2004) Some would halt lipolysis tx pending safety data. Skin Allergy News 35:26
Fat-Melting Fad (2004) Too Good to Be True? ASAPS news release, pp 1–2
Rosen D (2007) PC/DC and Its Contemplated Use. Personal communication
Bush AM (2007) State decides to regulate substances used in weight loss. The Capital Journal. Available at http://www.cjonline.com
Veroffentlichungen (2006) Available at http://www.//netzwerk-lipolyse.de
Rittes PG (2006) Why ANVISA Banned the Use of Lipostabil for Injection Lipolysis in Brazil. Personal communication. International Mesolipotherapy Society instructional course, Las Vegas
Hexsel D et al (2005) Cosmetic use of injectable phosphatidylcholine on the face. Otolarngol Clin North Am 38:1119–1129
Rotunda AM, Kolodney MS (2006) Mesotherapy and phosphatidylcholine injections: historical clarification and review. Derm Surg 32(4):465–480
Meissner C (2005) Complications With Lipodissolve. First International Convention for Lipodissolve, Salzburg, Austria
Duncan DI (2006) Precision in Technique: Injection Lipolysis. IMCAS, Paris
Rotunda AM, Ablon G, Kolodney MS (2005) Lipomas treated with subcutaneous injections of sodium deoxycholate. J Am Acad Dermatol 53:973–978
Duncan DI (2007) Noninvasive Correction of Postsurgical Deformities. ASAPS annual meeting, New York
Hasengschwandtner F (2005) Injection Lipolysis Basics. First International Convention for Lipodissolve, Salzburg, Austria
Duncan DI (2007) Dispersion Studies. Instructional course, Global Network Lipolysis
Laddy S (2007) MasterPharm conference call
Duncan DI (2006) Technique of Injection Lipolysis. QMP annual meeting, Chicago
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Duncan, D.I., Palmer, M. Fat Reduction Using Phosphatidylcholine/Sodium Deoxycholate Injections: Standard of Practice. Aesth Plast Surg 32, 858–872 (2008). https://doi.org/10.1007/s00266-008-9188-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-008-9188-9